Compare with KOPRAN. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs KOPRAN. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES KOPRAN. ZIM LABORATORIES/
KOPRAN.
 
P/E (TTM) x 40.7 24.3 167.4% View Chart
P/BV x 1.6 5.4 29.6% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ZIM LABORATORIES   KOPRAN.
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
KOPRAN.
Mar-21
ZIM LABORATORIES/
KOPRAN.
5-Yr Chart
Click to enlarge
High Rs131146 89.8%   
Low Rs5322 244.1%   
Sales per share (Unadj.) Rs189.2113.7 166.4%  
Earnings per share (Unadj.) Rs4.514.2 31.6%  
Cash flow per share (Unadj.) Rs14.216.6 85.7%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Avg Dividend yield %01.8 0.0%  
Book value per share (Unadj.) Rs99.056.7 174.7%  
Shares outstanding (eoy) m16.2443.25 37.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.50.7 65.9%   
Avg P/E ratio x20.55.9 346.7%  
P/CF ratio (eoy) x6.55.1 128.0%  
Price / Book Value ratio x0.91.5 62.8%  
Dividend payout %010.5 0.0%   
Avg Mkt Cap Rs m1,4973,634 41.2%   
No. of employees `000NANA-   
Total wages/salary Rs m358372 96.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,0734,918 62.5%  
Other income Rs m23182 12.9%   
Total revenues Rs m3,0965,100 60.7%   
Gross profit Rs m346816 42.4%  
Depreciation Rs m158102 154.9%   
Interest Rs m10962 174.7%   
Profit before tax Rs m102833 12.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m29217 13.4%   
Profit after tax Rs m73616 11.9%  
Gross profit margin %11.316.6 67.8%  
Effective tax rate %28.526.1 109.2%   
Net profit margin %2.412.5 19.0%  
BALANCE SHEET DATA
Current assets Rs m1,9182,769 69.2%   
Current liabilities Rs m1,4201,607 88.4%   
Net working cap to sales %16.223.6 68.5%  
Current ratio x1.41.7 78.3%  
Inventory Days Days165 288.0%  
Debtors Days Days858891 96.3%  
Net fixed assets Rs m1,3041,624 80.3%   
Share capital Rs m162433 37.6%   
"Free" reserves Rs m1,4452,018 71.6%   
Net worth Rs m1,6082,450 65.6%   
Long term debt Rs m218212 102.9%   
Total assets Rs m3,2224,394 73.3%  
Interest coverage x1.914.4 13.5%   
Debt to equity ratio x0.10.1 156.9%  
Sales to assets ratio x1.01.1 85.2%   
Return on assets %5.715.4 36.6%  
Return on equity %4.625.1 18.1%  
Return on capital %11.633.6 34.4%  
Exports to sales %67.440.5 166.6%   
Imports to sales %4.16.5 63.5%   
Exports (fob) Rs m2,0721,990 104.1%   
Imports (cif) Rs m127321 39.7%   
Fx inflow Rs m2,1401,990 107.5%   
Fx outflow Rs m127374 34.1%   
Net fx Rs m2,0121,617 124.5%   
CASH FLOW
From Operations Rs m319600 53.1%  
From Investments Rs m-59-244 24.1%  
From Financial Activity Rs m-260-346 75.1%  
Net Cashflow Rs m-110 -7.1%  

Share Holding

Indian Promoters % 33.3 43.8 76.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.9 -  
FIIs % 0.0 0.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 56.2 118.7%  
Shareholders   4,610 37,822 12.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

SGX Nifty Down 67 Points; Indicates Negative Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a negative note today. At 8:00 am, it was trading down by 67 points, or 0.4% lower at 18,207 levels.

Related Views on News

KOPRAN. 2020-21 Annual Report Analysis (Annual Result Update)

Nov 9, 2021 | Updated on Nov 9, 2021

Here's an analysis of the annual report of KOPRAN. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of KOPRAN.. Also includes updates on the valuation of KOPRAN..

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

My Best Sectors for 2022(Fast Profits Daily)

Jan 4, 2022

My top 2 sectors for 2022 might surprise you.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


Jan 14, 2022 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 8-QTR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS